Mouse Anti-GSTM3 Recombinant Antibody (7A10) (CBMAB-1313CQ)

Chen, T., Jinlin, D., Wang, F., Yuan, Z., Xue, J., Lu, T., ... & Zhang, Y. (2022). GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling. Cancer Letters, 538, 215692.

Llavanera, M., Delgado-Bermúdez, A., Mateo-Otero, Y., Padilla, L., Romeu, X., Roca, J., ... & Yeste, M. (2020). Exploring seminal plasma GSTM3 as a quality and in vivo fertility biomarker in pigs—relationship with sperm morphology. Antioxidants, 9(8), 741.

Juang, J. M. J., Binda, A., Lee, S. J., Hwang, J. J., Chen, W. J., Liu, Y. B., ... & Antzelevitch, C. (2020). GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death. EBioMedicine, 57, 102843.

Wang, S., Yang, J., You, L., Dai, M., & Zhao, Y. (2020). GSTM3 function and polymorphism in cancer: emerging but promising. Cancer management and research, 12, 10377.

Moghimi, M., Sobhan, M. R., Jarahzadeh, M. H., Morovati-Sharifabad, M., Aghili, K., Ahrar, H., ... & Neamatzadeh, H. (2019). Association of GSTM1, GSTT1, GSTM3, and GSTP1 genes polymorphisms with susceptibility to osteosarcoma: a case-control study and meta-analysis. Asian Pacific Journal of Cancer Prevention: APJCP, 20(3), 675.

Li, G., Cai, Y., Wang, C., Huang, M., & Chen, J. (2019). LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells. Journal of neuro-oncology, 143, 525-536.

Llavanera, M., Delgado-Bermúdez, A., Fernandez-Fuertes, B., Recuero, S., Mateo, Y., Bonet, S., ... & Yeste, M. (2019). GSTM3, but not IZUMO1, is a cryotolerance marker of boar sperm. Journal of animal science and biotechnology, 10(1), 1-11.

Checa-Rojas, A., Delgadillo-Silva, L. F., del Castillo Velasco-Herrera, M., Andrade-Domínguez, A., Gil, J., Santillán, O., ... & Encarnación-Guevara, S. (2018). GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer. Oncotarget, 9(31), 21696.

Wang, Y., Yang, Z. Y., Chen, Y. H., Li, F., Shen, H., Yu, Y., ... & Shen, Z. Y. (2018). A novel functional polymorphism of GSTM 3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR‐556 binding. Journal of Cellular and Molecular Medicine, 22(6), 3005-3015.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols